Here, rfxcel CEO Glenn Abood explains how serialisation software can unlock additional value beyond regulatory compliance.
Ace up the sleeve
The pharmaceutical industry’s understanding of serialisation is maturing as companies slowly begin to recognise the added business value supply chain traceability can provide. Historically, the industry’s focus on serialisation has been driven by the need to satisfy evolving regulations. However, progressive companies are finally realising that the benefits of traceability extend far beyond compliance.